Cargando…

The Prognostic Value of Systemic Inflammation Response Index in Cholangiocarcinoma Patients

PURPOSE: We determined the prognostic value of the systemic inflammation response index (SIRI) in patients with cholangiocarcinoma after surgery and constructed a survival prediction model based on SIRI. PATIENTS AND METHODS: We recruited 328 patients with histopathologically confirmed cholangiocarc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Bao, Hu, Wenmo, Su, Si, Xu, Haifeng, Lu, Xin, Sang, Xinting, Yang, Huayu, Mao, Yilei, Du, Shunda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364361/ https://www.ncbi.nlm.nih.gov/pubmed/34408489 http://dx.doi.org/10.2147/CMAR.S317954

Ejemplares similares

The Impacts of Systemic Immune-Inflammation Index on Clinical Outcomes in Gallbladder Carcinoma
por: Sun, Lejia, et al.
Publicado: (2020)

Comparison of the Prognostic Value of Platelet-Related Indices in Biliary Tract Cancer Undergoing Surgical Resection
por: Sun, Lejia, et al.
Publicado: (2021)

High Systemic Inflammation Response Index (SIRI) Indicates Poor Outcome in Gallbladder Cancer Patients with Surgical Resection: A Single Institution Experience in China
por: Sun, Lejia, et al.
Publicado: (2020)

Controlling nutritional status score as a prognostic marker to predict overall survival in resected biliary tract cancers
por: Sun, Lejia, et al.
Publicado: (2021)

The Clinicopathological and Prognostic Value of PD-L1 Expression in Cholangiocarcinoma: A Meta-Analysis
por: Xu, Gang, et al.
Publicado: (2019)

Prognostic Nomogram That Predicts Overall Survival of Patients with Distal Cholangiocarcinoma After Pancreatoduodenectomy
por: Chen, Qiao, et al.
Publicado: (2020)

Preoperative Bilirubin-Adjusted Carbohydrate Antigen 19-9 as a Prognostic Factor for Extrahepatic Cholangiocarcinoma Patients at a Single Center
por: Li, Jiayi, et al.
Publicado: (2020)

Preoperative Immune Prognostic Index Can Predict the Clinical Outcomes of Patients with Gallbladder Cancer: Single-Center Experience
por: Sun, Lejia, et al.
Publicado: (2020)

Prognostic Value of the Albumin-to-γ-glutamyltransferase Ratio for Gallbladder Cancer Patients and Establishing a Nomogram for Overall Survival
por: Sun, Lejia, et al.
Publicado: (2021)

Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis
por: Sun, Lejia, et al.
Publicado: (2017)

Current trends and research topics regarding liver 3D bioprinting: A bibliometric analysis research
por: Jin, Bao, et al.
Publicado: (2022)

Immune checkpoint inhibitor‐related molecular markers predict prognosis in extrahepatic cholangiocarcinoma
por: Jin, Bao, et al.
Publicado: (2023)

Radiomics based on artificial intelligence in liver diseases: where are we?
por: Hu, Wenmo, et al.
Publicado: (2020)

Laparoscopic hepatectomy for patients who received enterostomy
por: Jin, Bao, et al.
Publicado: (2019)

In situ Detecting Lipids as Potential Biomarkers for the Diagnosis and Prognosis of Intrahepatic Cholangiocarcinoma
por: Li, Jiayi, et al.
Publicado: (2022)

Comprehensive analysis of coagulation indices for predicting survival in patients with biliary tract cancer
por: Ke, Xindi, et al.
Publicado: (2021)

Exploring the function of stromal cells in cholangiocarcinoma by three-dimensional bioprinting immune microenvironment model
por: Li, Changcan, et al.
Publicado: (2022)

Differential Diagnosis of Immunoglobulin G4-associated Cholangitis From Cholangiocarcinoma
por: Du, Shunda, et al.
Publicado: (2016)

Value of Quantitative and Qualitative Analyses of Circulating Cell-Free DNA as Diagnostic Tools for Hepatocellular Carcinoma: A Meta-Analysis
por: Liao, Wenjun, et al.
Publicado: (2015)

Application and Progress of Cultured Models of Gallbladder Carcinoma
por: Xing, Jiali, et al.
Publicado: (2023)

Albumin Binding Function: The Potential Earliest Indicator for Liver Function Damage
por: Ge, Penglei, et al.
Publicado: (2016)

Diagnosis and treatment of a diaphragmatic pheochromocytoma: A case report
por: Wu, Xiangan, et al.
Publicado: (2020)

Reassessment of different criteria for diagnosing post-hepatectomy liver failure: a single-center study of 1683 hepatectomy
por: Zheng, Yongchang, et al.
Publicado: (2017)

Integrated analysis of serum lipid profile for predicting clinical outcomes of patients with malignant biliary tumor
por: Sun, Lejia, et al.
Publicado: (2020)

Application of associating liver partition and portal vein ligation for staged hepatectomy for hepatocellular carcinoma related to hepatitis B virus: comparison with traditional one-stage right hepatectomy
por: Zhang, Junwei, et al.
Publicado: (2020)

Prognostic value of inflammation-based indexes for intrahepatic cholangiocarcinoma following curative resection
por: Wu, Yunhua, et al.
Publicado: (2019)

Perioperative management of patients with liver cancer complicated with sarcopenia
por: Xing, Jiali, et al.
Publicado: (2022)

Multiple Primary Malignancies in Patients With Hepatocellular Carcinoma: A Largest Series With 26-Year Follow-Up
por: Xu, Wei, et al.
Publicado: (2016)

Management of intrahepatic recurrence after resection for hepatocellular carcinoma exceeding the barcelona clinic liver cancer criteria
por: Xu, Wei, et al.
Publicado: (2017)

Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020)

Safety and Perioperative Outcomes of Laparoscopic vs. Open Hepatectomy of Central-Located Liver Lesions: A Multicenter, Propensity Score-Matched, Retrospective Cohort Study
por: Jin, Bao, et al.
Publicado: (2023)

Association of a novel PKHD1 mutation in a family with autosomal dominant polycystic liver disease
por: Wang, Jiaru, et al.
Publicado: (2021)

Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinoma
por: Li, Hanyu, et al.
Publicado: (2019)

Evolutions of the Management of Colorectal Cancer Liver Metastasis: A Bibliometric Analysis
por: Jin, Bao, et al.
Publicado: (2021)

Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine Tumors
por: Du, Shunda, et al.
Publicado: (2015)

Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure
por: Yang, Huayu, et al.
Publicado: (2021)

Novel Drug Candidate Prediction for Intrahepatic Cholangiocarcinoma via Hub Gene Network Analysis and Connectivity Mapping
por: Xiao, Yao, et al.
Publicado: (2022)

Surgical Resection Improves the Outcome of the Patients With Neuroendocrine Tumor Liver Metastases: Large Data From Asia
por: Du, Shunda, et al.
Publicado: (2015)

Noninvasive detection of tumor-associated mutations from circulating cell-free DNA in hepatocellular carcinoma patients by targeted deep sequencing
por: Liao, Wenjun, et al.
Publicado: (2016)

Quantitative definitions of prognostic indicators of resectable pancreatic cancer
por: Sun, Hang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dishbuu8quj7s91vavj5qae5fj